Boston Scientific Corporation Stock Prediction and Forecast [BSX]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 16 Jan 2026, 04:26 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Boston Scientific Corporation Stock Prediction and Forecast [BSX]](https://i.ytimg.com/vi/ow_C9MWRz34/hqdefault.jpg)
AI-generated source summary
Boston Scientific Corporation (BSX) is identified as a strong sell candidate with a current score of -5.253 and a status downgrade from sell to strong sell on January 15th, 2026. The stock closed at $90.03, experiencing a -3.96% decline on the last trading day, marking its sixth consecutive day of decrease. Technical analysis indicates the stock is at the lower end of a wide and declining short-term trend. Resistance levels are noted at $95.47 and $96.01, with support levels at $87.97, $87.09, and $85.60. A breach below the $88.85 trend floor would signal a stronger decline. The 3-month forecast projects a potential decrease of approximately 7.2%, with a 12-month analysis indicating a -4.31% change, potentially ranging between $82.25 and $101.83. Volume increased on falling prices, suggesting an early warning. Moving Average Convergence Divergence (MACD) and multiple Moving Averages (Short and Long) are issuing sell signals. Insider trading shows a negative power of -18.197, with significantly more shares sold (1,220,226) than bought (814,881) in the last 100 transactions. The price-to-earnings (P/E) ratio is high at 47.85, indicating potential overvaluation. For Friday, January 16th, the stock is expected to open down by -$0.645 at $89.39.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
